Market Cap 241.89M
Revenue (ttm) 32.31M
Net Income (ttm) -237.09M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -733.80%
Debt to Equity Ratio 0.00
Volume 2,418,610
Avg Vol 2,053,596
Day's Range N/A - N/A
Shares Out 89.92M
Stochastic %K 62%
Beta 2.16
Analysts Sell
Price Target $3.67

Company Profile

Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. The company develops a proprietary gene editing platform based on CRISPR technology. It has a research collaboration with Juno Therapeutics, Inc. to develop alpha-beta T-cell experimental medicines for the treatment of solid and liquid tumors. The company was formerly known as Gengine, Inc. and changed its name to Editas Medicine, Inc. in No...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 401 9000
Address:
11 Hurley Street, Cambridge, United States
Proverbs22_7
Proverbs22_7 Sep. 16 at 7:38 PM
$EDIT - can it break the 2.89 🤞🏽
1 · Reply
alexx013
alexx013 Sep. 16 at 7:24 PM
$EDIT it's alive
0 · Reply
highnihilism
highnihilism Sep. 16 at 6:52 PM
IWM: Russell 2000 → $EDIT Editas Medicine $BLND Blend Labs $KOS Kosmos Energy $BLND Blend Labs $RDNT Radnet
1 · Reply
0x126
0x126 Sep. 16 at 6:14 PM
$EDIT nice push to the sector gains
0 · Reply
Swing22
Swing22 Sep. 16 at 4:35 PM
$EDIT aka the poor man’s CRSP
0 · Reply
3DBuilds
3DBuilds Sep. 16 at 9:47 AM
0 · Reply
Whoami1989
Whoami1989 Sep. 15 at 2:20 PM
$EDIT if you invest in this stock, you are dumbest of the dumb asses including me
2 · Reply
0x126
0x126 Sep. 14 at 6:10 PM
$EDIT start of the year
0 · Reply
0x126
0x126 Sep. 14 at 11:48 AM
$EDIT what a monthly flag
0 · Reply
PaulLaurent
PaulLaurent Sep. 13 at 9:26 AM
🌀 Weekly Swing Trade Recap $ASST – +280% from our entry zone. Big winner; multiple scale-out points. $COCP – +169% from our entry zone. Trend held; great adds on strength. $PMVP – +48% from our entry zone. Solid follow-through; trims into spikes paid. $LWLG – Tagged the +10% profit zone, then dumped immediately; quick take-profit was key. $EDIT – Breakeven. No decisive push; preserved capital. XRTX – Breakeven. Low momentum; no reason to force it. Takeaways: 3 green, 1 quick tap-and-fade, 2 flat. Keep scaling into strength, move stops to breakeven after PT1, and stay ruthless about exits when momentum stalls.
2 · Reply
Latest News on EDIT
Editas Medicine, Inc. - Special Call

Sep 2, 2025, 11:14 AM EDT - 14 days ago

Editas Medicine, Inc. - Special Call


Editas Medicine to Participate in Upcoming Investor Conferences

Aug 27, 2025, 9:00 AM EDT - 20 days ago

Editas Medicine to Participate in Upcoming Investor Conferences


Editas Medicine Announces Chief Financial Officer Transition

Mar 20, 2025, 4:01 PM EDT - 6 months ago

Editas Medicine Announces Chief Financial Officer Transition


Editas Medicine, Inc. (EDIT) Strategic Update Call Transcript

Oct 22, 2024, 11:45 AM EDT - 11 months ago

Editas Medicine, Inc. (EDIT) Strategic Update Call Transcript


Editas Medicine: A Risk/Reward Worth Considering

Sep 25, 2024, 11:46 AM EDT - 1 year ago

Editas Medicine: A Risk/Reward Worth Considering


Editas Medicine, Inc. (EDIT) Q2 2024 Earnings Call Transcript

Aug 7, 2024, 12:03 PM EDT - 1 year ago

Editas Medicine, Inc. (EDIT) Q2 2024 Earnings Call Transcript


Proverbs22_7
Proverbs22_7 Sep. 16 at 7:38 PM
$EDIT - can it break the 2.89 🤞🏽
1 · Reply
alexx013
alexx013 Sep. 16 at 7:24 PM
$EDIT it's alive
0 · Reply
highnihilism
highnihilism Sep. 16 at 6:52 PM
IWM: Russell 2000 → $EDIT Editas Medicine $BLND Blend Labs $KOS Kosmos Energy $BLND Blend Labs $RDNT Radnet
1 · Reply
0x126
0x126 Sep. 16 at 6:14 PM
$EDIT nice push to the sector gains
0 · Reply
Swing22
Swing22 Sep. 16 at 4:35 PM
$EDIT aka the poor man’s CRSP
0 · Reply
3DBuilds
3DBuilds Sep. 16 at 9:47 AM
0 · Reply
Whoami1989
Whoami1989 Sep. 15 at 2:20 PM
$EDIT if you invest in this stock, you are dumbest of the dumb asses including me
2 · Reply
0x126
0x126 Sep. 14 at 6:10 PM
$EDIT start of the year
0 · Reply
0x126
0x126 Sep. 14 at 11:48 AM
$EDIT what a monthly flag
0 · Reply
PaulLaurent
PaulLaurent Sep. 13 at 9:26 AM
🌀 Weekly Swing Trade Recap $ASST – +280% from our entry zone. Big winner; multiple scale-out points. $COCP – +169% from our entry zone. Trend held; great adds on strength. $PMVP – +48% from our entry zone. Solid follow-through; trims into spikes paid. $LWLG – Tagged the +10% profit zone, then dumped immediately; quick take-profit was key. $EDIT – Breakeven. No decisive push; preserved capital. XRTX – Breakeven. Low momentum; no reason to force it. Takeaways: 3 green, 1 quick tap-and-fade, 2 flat. Keep scaling into strength, move stops to breakeven after PT1, and stay ruthless about exits when momentum stalls.
2 · Reply
0x126
0x126 Sep. 12 at 4:56 PM
0 · Reply
0x126
0x126 Sep. 12 at 4:55 PM
$EDIT after years of downwards, sideways is so lovely
0 · Reply
Robert_Dempster
Robert_Dempster Sep. 12 at 1:14 PM
$EDIT 📈🐂
0 · Reply
Arcides
Arcides Sep. 11 at 8:51 PM
$EDIT working a wide base.
0 · Reply
3DBuilds
3DBuilds Sep. 11 at 6:28 PM
$EDIT 💯 💰
0 · Reply
Robert_Dempster
Robert_Dempster Sep. 11 at 12:38 PM
$EDIT yields down three handle on the 10 year🐂📈
0 · Reply
DocPharm
DocPharm Sep. 10 at 10:21 PM
$ABUS likely for one of Genevant’s partners They have a ton of codeveloped products - it sounds like at least one is showing promise $NVO $BNTX $EDIT $TAK come to mind firstly
1 · Reply
3DBuilds
3DBuilds Sep. 10 at 7:38 PM
0 · Reply
Whoami1989
Whoami1989 Sep. 10 at 7:36 PM
$EDIT who would invest in this mf
0 · Reply
Whoami1989
Whoami1989 Sep. 10 at 7:04 PM
$EDIT where are the cheer leaders
0 · Reply
Whoami1989
Whoami1989 Sep. 10 at 3:20 PM
$EDIT this mf is dead
0 · Reply
Robert_Dempster
Robert_Dempster Sep. 10 at 1:33 PM
$EDIT ppi downside surprise today good news for rate cuts and for stocks📈🐂
1 · Reply